University of Wisconsin-MadisonUW-Madison biomanufacturer offers essential gene-transfer capacityUniversity of Wisconsin-MadisonAdeno associated virus samples are prepared for quality control analysis in a robotic liquid handler. Waisman Biomanufacturi… Continue reading
University of Wisconsin-MadisonUW-Madison biomanufacturer offers essential gene-transfer capacityUniversity of Wisconsin-MadisonAdeno associated virus samples are prepared for quality control analysis in a robotic liquid handler. Waisman Biomanufacturi… Continue reading
University of Wisconsin-MadisonUW-Madison biomanufacturer offers essential gene-transfer capacityUniversity of Wisconsin-MadisonAdeno associated virus samples are prepared for quality control analysis in a robotic liquid handler. Waisman Biomanufacturi… Continue reading
Ars TechnicaStem cell clinics that blinded women used smallpox vaccine go to …Ars TechnicaAs promised, FDA got DOJ to crackdown on shady, dangerous stem cell clinics.FDA Cracks Down on Stem Cell ClinicsNBC 5 Dallas-Fort WorthThe FDA Is Taking Two Sha… Continue reading
Rare Disease Report |
Could CRISPR Technology Cure a Rare Blindness?
Rare Disease Report Recently, CRISPR/Cas9 technology has made waves throughout the rare disease community, exhibiting the potential to improve conditions for patients with Huntington’s disease (HD), Duchenne muscular dystrophy (DMD), and other rare diseases. CRISPR-based treatment can restore retinal function in mice with eye diseaseNews-Medical.net |
Rare Disease Report |
Could CRISPR Technology Cure a Rare Blindness?
Rare Disease Report Recently, CRISPR/Cas9 technology has made waves throughout the rare disease community, exhibiting the potential to improve conditions for patients with Huntington’s disease (HD), Duchenne muscular dystrophy (DMD), and other rare diseases. CRISPR-based treatment can restore retinal function in mice with eye diseaseNews-Medical.net |
|
Is Tumor Mutational Burden Really ‘Ready for Primetime’ as a New Immunotherapy Biomarker?
Medscape H. Jack West, MD: Hello. I’m Jack West, medical director of the Thoracic Oncology Program at Swedish Cancer Institute in Seattle. Welcome to Medscape Oncology Insights. Joining me today is Hossein Borghaei, chief of thoracic medical oncology at Fox … |
Cancer Therapy Advisor |
Early Success Gives Hope for CAR T-Cell Therapy in Multiple Myeloma
Cancer Therapy Advisor Given as a single treatment, CAR T-cell therapy uses a patient’s own immune system to fight their disease. Blood is collected from the patient and T-cells are separated and engineered to express and target specific CARs. We have been able to extend the … |